SYMPTOM IMPROVEMENT ASSOCIATED WITH LURASIDONE TREATMENT OF CHILDREN AND ADOLESCENTS WITH BIPOLAR I DEPRESSION: RESULTS OF A SHORT-TERM PLACEBO-CONTROLLED TRIAL

被引：1
|
作者：
Singh, Manpreet K. [1 ]
Goldman, Robert [2 ]
Tocco, Michael [2 ]
Pikalov, Andrei A. [2 ]
Deng, Ling [2 ]
Cucchiaro, Josephine [2 ]
Loebel, Antony [2 ]
机构：
[1] Stanford Univ, Sch Med, Stanford, CA 94305 USA
[2] Sunovion Pharmaceut Inc, Marlborough, MA USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY | 2017年 / 56卷 / 10期
关键词：
D O I：
10.1016/j.jaac.2017.09.333
中图分类号：
B844 [发展心理学（人类心理学）];
学科分类号：
040202 ;
摘要：
5.50
引用
收藏
页码：S271 / S272
页数：3
相关论文
共 50 条
  • [21] Olanzapine/Fluoxetine Combination in Children and Adolescents With Bipolar I Depression: A Randomized, Double-Blind, Placebo-Controlled Trial
    Detke, Holland C.
    DelBello, Melissa P.
    Landry, John
    Usher, Roland W.
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2015, 54 (03): : 217 - 224
  • [22] A placebo-controlled trial of venlafaxine XR in the short-term treatment of panic disorder
    Liebowtiz, M
    Asnis, G
    Tzanis, E
    Whitaker, T
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S370 - S370
  • [23] Lurasidone in the Treatment of Bipolar Depression With Mixed (Subsyndromal Hypomanic) Features: Post Hoc Analysis of a Randomized Placebo-Controlled Trial
    McIntyre, Roger S.
    Cucchiaro, Josephine
    Pikalov, Andrei
    Kroger, Hans
    Loebel, Antony
    JOURNAL OF CLINICAL PSYCHIATRY, 2015, 76 (04) : 398 - 405
  • [24] Effect of lurasidone on weight and metabolic parameters : Results from pooled short-term placebo-controlled trials in schizophrenia
    Pikalov, A.
    Silva, R.
    Cucchiaro, J.
    Hsu, J.
    Xu, J.
    Loebel, A.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2012, 15 : 124 - 125
  • [25] Short-term treatment with zanamivir to prevent influenza: Results of a placebo-controlled study
    Kaiser, L
    Henry, D
    Flack, NP
    Keene, O
    Hayden, FG
    CLINICAL INFECTIOUS DISEASES, 2000, 30 (03) : 587 - 589
  • [26] Lurasidone adjunctive to lithium or valproate for the treatment of bipolar I depression: results of a 6-week, double-blind, placebo-controlled study
    Loebel, A.
    Cucchiaro, J.
    Silva, R.
    Hsu, J.
    Sarma, K.
    Sachs, G.
    Calabrese, J. R.
    BIPOLAR DISORDERS, 2013, 15 : 137 - 138
  • [27] Fluoxetine for acute treatment of depression in children and adolescents: A placebo-controlled, randomized clinical trial
    Emslie, GJ
    Heiligenstein, JH
    Hoog, SL
    Judge, R
    Brown, E
    Nilsson, M
    BIOLOGICAL PSYCHIATRY, 2001, 49 (08) : 158S - 158S
  • [28] Fluoxetine for acute treatment of depression in children and adolescents: A placebo-controlled, randomized clinical trial
    Emslie, GJ
    Heiligenstein, JH
    Wagner, KD
    Hoog, SL
    Ernest, DE
    Brown, E
    Nilsson, M
    Jacobson, JG
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2002, 41 (10): : 1205 - 1215
  • [29] EFFECT OF LURASIDONE ON NEUROCOGNITIVE PERFORMANCE IN ADOLESCENTS WITH SCHIZOPHRENIA: RESULTS FROM A PLACEBO-CONTROLLED SHORT-TERM STUDY AND AN OPEN-LABEL EXTENSION STUDY
    Harvey, Philip D.
    Goldman, Robert
    Tocco, Michael
    Deng, Ling
    Cucchiaro, Josephine
    Loebel, Antony
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2017, 56 (10): : S175 - S176
  • [30] Efficacy and safety of lurasidone in bipolar depression: results from two, double blind, placebo-controlled studies
    Loebel, A.
    Cucchiaro, J.
    Silva, R.
    Sarma, K.
    Kroger, H.
    Calabrese, J.
    Sachs, G.
    Grossman, F.
    Pikalov, A.
    BIPOLAR DISORDERS, 2014, 16 : 131 - 132
12345